Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer

Tempus AI · with Blood Cancer United · NCT07756034

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Any age listed · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
1000
US sites recruiting
1
Study start
August 2026
Record last updated
August 10, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study entails enrolling participants that have been diagnosed with cancer to Olivia, a commercially available AI-enabled personal health platform developed by Tempus.

Olivia will serve as the primary interface for eConsent and enrollment into the registry. The platform will also help create a retrospective and prospective registry by working with over 1,000 healthcare systems to combine electronic health records (EHR) and Patient Reported Outcomes (PROs) in a single spot.

There may be sub-studies as an add-on to this parent protocol. The sub-studies will address specific goals of the targeted research activities and will usually include additional information specific to each research study.

Conditions: Cancer; Solid Tumor Cancer; Pediatric Acute Myeloid Leukemia; Hematologic Malignancies

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

ONCO-OLIVIA Registry

Inclusion Criteria

  • Adults or children (all ages) with a pathologically confirmed diagnosis of cancer (solid tumor or hematologic malignancy) documented in the medical record; disease-specific cohorts may further define subtypes (e.g., stage, biomarker)
  • Receiving care in the United States and/or U.S. Territories
  • Participant (and/or legally authorized representative) is able and willing to provide electronic informed consent/permission and authorization via Olivia; with re-consent at age of eighteen if applicable
  • Willing to authorize medical record retrieval under HIPAA Right of Access and/or TEFCA IAS
  • Access to a smartphone, tablet, or web-enabled device for remote participation (directly or via caregiver) for eConsent and optional surveys

Exclusion Criteria

  • Not Applicable

Substudy OLV002: Pediatric Acute Myeloid Leukemia (pAML):

Inclusion Criteria

  • Receiving or have received care in the United States and/or U.S. Territories
  • Participant (and/or legally authorized representative) is able and willing to provide electronic informed consent/permission and authorization via the platform; with re-consent at age of eighteen if applicable
  • Legally authorized representative of participant who is deceased is able and willing to provide electronic informed consent/permission and authorization via the platform
  • Willing to authorize medical record retrieval under HIPAA Right of Access and/or TEFCA IAS
  • Access to a smartphone, tablet, or web-enabled device for remote participation (directly or via caregiver) for eConsent and cohort dependent PROs/surveys
  • Pediatric patients with a confirmed diagnosis of Acute Myeloid Leukemia (AML) including the following AML subtypes per WHO/ICC classification: AML with core-binding factor rearrangements (AML-CBF), AML with inv(16) (AML-NV16), acute promyelocytic leukemia (APL), AML with KMT2A rearrangement (AML-KMT2A), AML with mutated NPM1 (AML-NPM1), AML with bZIP CEBPA mutations (AML-bZIP), AML with MECOM rearrangement

Exclusion Criteria

  • Suspected but unconfirmed acute myeloid leukemia

Recruiting US locations

  • Tempus AI

    Chicago, IL 60654

    Site contact: Mark Shapiro · 833-514-4187 · support@oliviahealth.ai

Study contacts (from the official record)

  • Olivia Study Team · 833-514-4187 · support@oliviahealth.ai
All healthy volunteers studies in Illinois →
Tempus Open Link for Individual Voices in Innovative Analytics… (NCT07756034) | Bored Studies